Experts expect corporate tax inversions to survive new rules

AP reporter Tom Murphy interviewed Professor of Practice Donald Goldman in the wake of Pfizer’s decision to scrap a tax-saving $160-billion overseas merger.

AP reporter Tom Murphy interviewed Professor of Practice Donald Goldman in the wake of Pfizer Inc.’s decision to scrap a $160-billion overseas merger. The move is credited to President Obama’s recent moves to discourage corporations from relocating abroad, thereby trimming their tax bills. From Yahoo! Finance, April 6, 2016:

Pfizer cited the new regulations in scuttling its deal. These rules will make it harder for U.S. companies to find a foreign deal partner, said Donald Goldman, a professor at Arizona State University's W.P. Carey School of Business. He added that the regulations "will definitely have a chilling effect on inversions."